Trials / Conditions / ISS Stage III Plasma Cell Myeloma
ISS Stage III Plasma Cell Myeloma
4 registered clinical trials studyying ISS Stage III Plasma Cell Myeloma — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | Combination Treatment Therapy Approaches for the Treatment of High-Risk Multiple Myeloma, REACH Trial NCT05497804 | Mayo Clinic | Phase 2 |
| Completed | Pembrolizumab and Radiation Therapy in Patients With Relapsed or Refractory Multiple Myeloma NCT03267888 | Emory University | Phase 1 / Phase 2 |
| Recruiting | Personalized NK Cell Therapy in CBT NCT02727803 | M.D. Anderson Cancer Center | Phase 2 |
| Unknown | NK Cells in Cord Blood Transplantation NCT01619761 | M.D. Anderson Cancer Center | Phase 1 |